[1] Menard C, Pfau ML, Hodes GE, et al. Social stress induces neurovascular pathology promoting depression[J]. Nat Neurosci, 2017, 20(12): 1752-1760. [2] Zhu XH, Yan HC, Zhang J, et al. Intermittent hypoxia promotes hippocampal neurogenesis and produces antidepressant-like effects in adultrats[J]. J Neurosci, 2010, 30(38): 12653-12663. [3] 许 玲, 王德全, 任建民, 等. 2型糖尿病患者抑郁的患病率及其危险因素[J]. 中国糖尿病杂志, 2003, 11(1): 46-50. [4] Su WJ, Peng W, Gong H, et al. Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance[J]. J Neuroinflammation, 2017, 14: 210-212. [5] Wang YW, He SJ, Feng X, et al. Metformin: a review of its potential indications. [J]. Drug Des Devel Ther, 2017, 11: 2421-2429. [6] Shivavedi N, Kumar M, Tej GNVC, et al. Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats[J]. Brain Res, 2017, 1674: 1-9. [7] Keshavarzi S, Kermanshahi S, Karami L, et al. Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways [J]. Neurotoxicology, 2019, 72: 74-84. [8] Khedr SA, Elmelgy AA, El-Kharashi OA, et al. Metformin potentiates cognitive and antidepressant effects of fluoxetine in rats exposed to chronic restraint stress and high fat diet: potential involvement of hipp℃ampal c-Jun repression[J]. Naunyn Schmiedebergs Arch Pharmacol, 2018, 391(4): 407-422. [9] 林 霄. 二甲双胍对高原低氧认知损伤的保护效应及其作用机制的研究[D]. 合肥: 安徽医科大学, 2017. [10]赵 燕, 付 玉. 慢性应激抑郁状态对大鼠外周神经内分泌因子生物节律的影响[J]. 中国应用生理学杂志, 2017, 33(5): 398-402. [11]QIAO H, Li MX, Xu C, et al. Dendritic spines in depression: what we learned from animal models[J]. Neural Plast, 2016, 2016: 1-26. [12]杜 青, 王宇红, 赵洪庆, 等. 糖尿病并发抑郁症大鼠海马血脑屏障结构的损伤及其机制[J]. 中国应用生理学杂志, 2016, 32(6): 558-562. [13]Karki R, Kodamullil AT, Hofmann-Apitius M. Comorbidity analysis between Alzheimer’s disease and type 2 diabetes mellitus (T2DM) based on shared pathways and the role of T2DM drugs[J]. J Alzheimers Dis, 2017, 60(2): 721-731. [14]Katila N, Bhurtel S, Shadfar S, et al. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease[J]. Neuropharmacology, 2017, 125: 396-407. [15]Ould-Brahim F, Sarma SN, Syal C, et al. Metformin preconditioning of human induced pluripotent stem cell-derived neural stem cells promotes their engraftment and improves post-stroke regeneration and recovery [J]. Stem Cells Dev, 2018, 27(16): 1085-1096. |